These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15597757

  • 1. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging.
    Maia AC, Malheiros SM, da Rocha AJ, Stávale JN, Guimarães IF, Borges LR, Santos AJ, da Silva CJ, de Melo JG, Lanzoni OP, Gabbai AA, Ferraz FA.
    J Neurosurg; 2004 Dec; 101(6):970-6. PubMed ID: 15597757
    [Abstract] [Full Text] [Related]

  • 2. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas.
    Maia AC, Malheiros SM, da Rocha AJ, da Silva CJ, Gabbai AA, Ferraz FA, Stávale JN.
    AJNR Am J Neuroradiol; 2005 Apr; 26(4):777-83. PubMed ID: 15814920
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.
    Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S.
    Neuro Oncol; 2011 Apr; 13(4):447-55. PubMed ID: 21297125
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
    Chaskis C, Stadnik T, Michotte A, Van Rompaey K, D'Haens J.
    Acta Neurochir (Wien); 2006 Mar; 148(3):277-85; discussion 285. PubMed ID: 16421765
    [Abstract] [Full Text] [Related]

  • 8. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR.
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [Abstract] [Full Text] [Related]

  • 9. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.
    Barker FG, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD.
    Cancer; 1997 Sep 01; 80(5):936-41. PubMed ID: 9307194
    [Abstract] [Full Text] [Related]

  • 10. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ.
    Neurosurgery; 2006 Jun 01; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [Abstract] [Full Text] [Related]

  • 11. Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
    Lee SJ, Kim JH, Kim YM, Lee GK, Lee EJ, Park IS, Jung JM, Kang KH, Shin T.
    Korean J Radiol; 2001 Jun 01; 2(1):1-7. PubMed ID: 11752962
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
    Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F.
    Neuroradiology; 2006 Mar 01; 48(3):150-9. PubMed ID: 16470375
    [Abstract] [Full Text] [Related]

  • 13. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.
    Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, Yousry TA, Rees J, Waldman AD, Jäger HR.
    Radiology; 2009 Nov 01; 253(2):505-12. PubMed ID: 19789244
    [Abstract] [Full Text] [Related]

  • 14. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
    Shin JH, Lee HK, Kwun BD, Kim JS, Kang W, Choi CG, Suh DC.
    AJR Am J Roentgenol; 2002 Sep 01; 179(3):783-9. PubMed ID: 12185064
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?
    Fan GG, Deng QL, Wu ZH, Guo QY.
    Br J Radiol; 2006 Aug 01; 79(944):652-8. PubMed ID: 16641420
    [Abstract] [Full Text] [Related]

  • 16. Is it appropriate to redefine the indication for stereotactic brain biopsy in the MRI Era? Correlation with final histological diagnosis in supratentorial gliomas.
    Callovini GM.
    Minim Invasive Neurosurg; 2008 Apr 01; 51(2):109-13. PubMed ID: 18401825
    [Abstract] [Full Text] [Related]

  • 17. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
    Preul C, Kühn B, Lang EW, Mehdorn HM, Heller M, Link J.
    Eur J Radiol; 2003 Dec 01; 48(3):244-51. PubMed ID: 14652141
    [Abstract] [Full Text] [Related]

  • 18. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H, Steffensen E, Larsson EM.
    Acta Radiol; 2012 Feb 01; 53(1):95-101. PubMed ID: 22114021
    [Abstract] [Full Text] [Related]

  • 19. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A.
    Neuroradiology; 2019 May 01; 61(5):545-555. PubMed ID: 30712139
    [Abstract] [Full Text] [Related]

  • 20. Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.
    Gaudino S, Benenati M, Martucci M, Botto A, Infante A, Marrazzo A, Ramaglia A, Marziali G, Guadalupi P, Colosimo C.
    Radiol Med; 2020 Apr 01; 125(4):416-422. PubMed ID: 31916104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.